The article analyses the news on the field of non-profit clinical trials after the adoption of the Ministerial Decree on Health 30/11/2021, implementing the so-called Lorenzin Law. In particular, we will focus on two relevant and most problematic aspects. First of all the issues concerning the transfer of data and results of ab origine non-profit trials will be examined, verifying the critical issues related to property rights, including intellectual property rights, as well as multiple transfers. On the other hand, the profiles relating to the impact of the transfer on the protection of personal data of patients involved in the trials will be examined.
Whistleblowing and GDPR
16 November 2023
The recent extension of whistleblowing obligations for private entities will – hopefully – cast light on illicit behaviours in the corporate context. But the internal
